Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | EB499 | IM / LA |
Pt has a large area of discoloration, redness and warmth at and below injection site. Onset of sx reported to have started the following day.
none
none
prenatal otc
NKA
pt seen in office for f/u. Will continue to monitor.